It is an anti-tumor API, CAS No: 154361-50-9, molecular formula: C15H22FN3O6.

Market Analysis and Insights: Global Capecitabine API Market
The global Capecitabine API market was valued at US$ XX in 2020 and will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2022-2027.

Global Capecitabine API Scope and Market Size
The global Capecitabine API market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Capecitabine API market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

Segment by Type
Purity ≥ 98 %
Purity ≥ 99 %

Segment by Application
Capecitabine Tablets
Other

The Capecitabine API market is analysed and market size information is provided by regions (countries). Segment by Application, the Capecitabine API market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

By Company
Apotex Pharmachem
Shilpa Medicare Limited
Dr. Reddy's Laboratories
Scion Pharm Taiwan
Gland Chemicals
Acebright
Qilu Pharmaceutial
Aarti Industries
Cipla
Haizhou Pharma
Xinxiang Tuoxin Pharmaceutical
Xinxiang Best Pharmaceutical